DataMEDS AI Statistics
Total Valuation
DataMEDS AI has a market cap or net worth of $7.66 million. The enterprise value is $27.13 million.
Important Dates
The last earnings date was Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DataMEDS AI has 5.72 million shares outstanding. The number of shares has increased by 108.35% in one year.
| Current Share Class | 3.06M |
| Shares Outstanding | 5.72M |
| Shares Change (YoY) | +108.35% |
| Shares Change (QoQ) | +53.85% |
| Owned by Insiders (%) | 24.60% |
| Owned by Institutions (%) | 2.22% |
| Float | 1.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.00 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.14, with a Debt / Equity ratio of 116.15.
| Current Ratio | 0.14 |
| Quick Ratio | 0.10 |
| Debt / Equity | 116.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.37 |
Financial Efficiency
Return on equity (ROE) is -1,249.64% and return on invested capital (ROIC) is -69.83%.
| Return on Equity (ROE) | -1,249.64% |
| Return on Assets (ROA) | -94.78% |
| Return on Invested Capital (ROIC) | -69.83% |
| Return on Capital Employed (ROCE) | -3,599.69% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.17 |
| Inventory Turnover | 3.30 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -95.37% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -95.37% |
| 50-Day Moving Average | 2.47 |
| 200-Day Moving Average | 4.54 |
| Relative Strength Index (RSI) | 46.15 |
| Average Volume (20 Days) | 6,514,468 |
Short Selling Information
The latest short interest is 371,417, so 6.50% of the outstanding shares have been sold short.
| Short Interest | 371,417 |
| Short Previous Month | 476,294 |
| Short % of Shares Out | 6.50% |
| Short % of Float | 25.52% |
| Short Ratio (days to cover) | 0.10 |
Income Statement
In the last 12 months, DataMEDS AI had revenue of $7.68 million and -$43.37 million in losses. Loss per share was -$17.63.
| Revenue | 7.68M |
| Gross Profit | -7.07M |
| Operating Income | -29.53M |
| Pretax Income | -43.42M |
| Net Income | -43.37M |
| EBITDA | -27.66M |
| EBIT | -29.53M |
| Loss Per Share | -$17.63 |
Full Income Statement Balance Sheet
The company has $476,598 in cash and $19.94 million in debt, with a net cash position of -$19.47 million or -$3.40 per share.
| Cash & Cash Equivalents | 476,598 |
| Total Debt | 19.94M |
| Net Cash | -19.47M |
| Net Cash Per Share | -$3.40 |
| Equity (Book Value) | 171,695 |
| Book Value Per Share | -0.60 |
| Working Capital | -32.69M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -13.74M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.87M |
| Net Borrowing | 8.35M |
| Free Cash Flow | -12.08M |
| FCF Per Share | -$2.11 |
Full Cash Flow Statement Margins
| Gross Margin | -92.09% |
| Operating Margin | -384.58% |
| Pretax Margin | -565.48% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DataMEDS AI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -108.35% |
| Shareholder Yield | -108.35% |
| Earnings Yield | -1,315.82% |
| FCF Yield | -157.62% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 18.40% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on May 26, 2026. It was a reverse split with a ratio of 1:50.
| Last Split Date | May 26, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |